MedTrace Logo

Human Intestinal Peptides Evaluation and Research

NCT02532829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2016-10-25

No results posted yet for this study

Summary

The HIPER-1 study is a single centre cross sectional study in which a total of 240 participants (in different metabolic states and surgical models) will receive an Oral Mixed Meal Tolerance Test (OMTT). At baseline and after 30, 60 and 120 minutes the PYY levels, GLP-1 levels, glucose and insulin sensitivity will be measured. The primary endpoint of the study will be the area under the GLP-1 and Peptide - YY curves and insulin sensitivity following the OMTT.

Conditions

  • Obesity
  • Diabetes Mellitus, Type 2

Interventions

OTHER

blood sample analysis

Measurement of GLP-1, Peptide YY, Glucose and Insulin before and 30-60-120 minutes after Oral Mixed Meal Tolerance Test.

Sponsors & Collaborators

  • Turkish Metabolic Surgery Foundation

    lead OTHER

Principal Investigators

  • Alper Celik, MD · Turkish Metabolic Surgery Foundation

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-07-31
Completion
2016-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02532829 on ClinicalTrials.gov